banner

Latest News

Remote Monitoring Offers Opportunity to Improve Patient Care

A recent article highlighting Pillo Health: When Reena Sangar recently had a sore throat, she photographed it and sent the image to her doctor. Within 8 minutes, she had a message telling her how to manage it. “That kind of technology is transformative for me as a user,” said Sangar, head of digital and connective health at Ipsos, a global research and consulting fi...

Read More

Rapid 3D Printing Of High-Res, Viable Human Organs Possible

A recent  report about Prellis Biologics: It can be estimated that every year, in the United States alone, about 900,000 deaths can be prevented if there was no shortage of organs, or if transplants were not delayed and readily available to patients of organ failure. In fact, a Forbes study has ranked the lack of tissue transplants as one of the leading causes of death in Ameri...

Read More

Rocket Pharma - Initiation of Research Coverage by William Blair & Company Announced

From William Blair & Company: Initiation of Research Coverage for Two Gene Therapy Companies William Blair & Company initiated research coverage of two gene therapy companies—Krystal Biotech, Inc. (KRYS $15.07) and Rocket Pharmaceuticals, Inc. (RCKT $19.17). Analyst Raju Prasad said that shares of Krystal Biotech hold a positive risk/reward profile ahead of clinical dat...

Read More

Evonetix, Durham University Partner on £1.3M Project to Develop DNA Synthesis Method

From Genome Web: Evonetix, Durham University Partner on £1.3M Project to Develop DNA Synthesis Method British synthetic biology firm Evonetix said today that it has launched a £1.3 million ($1.7 million) project in partnership with Durham University to develop a proprietary method for DNA synthesis. Evonetix's core technology uses an addressable silicon array to direct the synthesi...

Read More



Catalog Hauls in $9M to Make DNA-Based Data Storage Commercially Viable

From Xconomy: Catalog Hauls in $9M to Make DNA-Based Data Storage Commercially Viable The practice of encoding data in DNA molecules could be inching closer to graduating from research labs to finding practical commercial use. In the coming years, the explosion of data being generated by computing devices could outstrip the supply of hard drives needed to store it, some indust...

Read More

Implantable 3D-printed organs could be coming sooner than you think

A recent article from Tech Crunch on Prellis Biologics: At MBC Biolabs, an incubator for biotech startups in San Francisco’s Dogpatch neighborhood, a team of scientists and interns working for the small startup Prellis Biologics have just taken a big step on the path toward developing viable 3D-printed organs for humans. The company, which was founded in 2016 by res...

Read More

New tech allows much faster 3D-printing of human tissue with capillaries

A New Atlas article about Prellis Biologics: Prellis Biologics has brought the science fiction dream of printing human organs for transplant a step forward by developing a fast, high-resolution 3D printing technique that can produce living tissue that includes viable blood-carrying capillaries. The new technique allows the cells to receive enough oxygen and nutrients to survive...

Read More

Rocket Pharmaceuticals to Join Russell 3000® and 2000® Indexes

Press release on Rocket Pharma: Rocket Pharmaceuticals to Join Russell 3000® and 2000® Indexes NEW YORK--(BUSINESS WIRE)--Jun. 22, 2018-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, announced that the Company will join the broad-market Russell 3000® and Russell 2000®Indexes. The ne...

Read More